Redox‐Responsive Dual Drug Delivery Nanosystem Suppresses Cancer Repopulation by Abrogating Doxorubicin‐Promoted Cancer Stemness, Metastasis, and Drug Resistance
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
Redox‐Responsive Dual Drug Delivery Nanosystem Suppresses Cancer Repopulation by Abrogating Doxorubicin‐Promoted Cancer Stemness, Metastasis, and Drug Resistance ; volume:6 ; number:7 ; year:2019 ; extent:16
Advanced science ; 6, Heft 7 (2019) (gesamt 16)
- Creator
-
Liu, Jia
Chang, Bingcheng
Li, Qilin
Xu, Luming
Liu, Xingxin
Wang, Guobin
Wang, Zheng
Wang, Lin
- DOI
-
10.1002/advs.201801987
- URN
-
urn:nbn:de:101:1-2022081306180905062916
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:21 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Liu, Jia
- Chang, Bingcheng
- Li, Qilin
- Xu, Luming
- Liu, Xingxin
- Wang, Guobin
- Wang, Zheng
- Wang, Lin
Other Objects (12)
Cancer Chemotherapy: Redox‐Responsive Dual Drug Delivery Nanosystem Suppresses Cancer Repopulation by Abrogating Doxorubicin‐Promoted Cancer Stemness, Metastasis, and Drug Resistance (Adv. Sci. 7/2019)
Three-Dimensional Tumor Models to Study Cancer Stemness-Mediated Drug Resistance
Stemness signature and targeted therapeutic drugs identification for Triple Negative Breast Cancer
HOXD3 Plays a Critical Role in Breast Cancer Stemness and Drug Resistance
Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance in drug-adapted cancer cells
Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance in drug-adapted cancer cells
Differential drug resistance acquisition to doxorubicin and paclitaxel in breast cancer cells
Treatment of experimental pancreatic cancer by doxorubicin-, mitoxantrone-, and irinitocan-drug eluting beads
PMN-MDSCs modulated by CCL20 from cancer cells promoted breast cancer cell stemness through CXCL2-CXCR2 pathway
Cardiac safety analysis of first-line chemotherapy drug pegylated liposomal doxorubicin in ovarian cancer
AR antagonists develop drug resistance through TOMM20 autophagic degradation-promoted transformation to neuroendocrine prostate cancer
Mapping knowledge translation and innovation processes in Cancer Drug Development: the case of liposomal doxorubicin
Cancer Chemotherapy: Redox‐Responsive Dual Drug Delivery Nanosystem Suppresses Cancer Repopulation by Abrogating Doxorubicin‐Promoted Cancer Stemness, Metastasis, and Drug Resistance (Adv. Sci. 7/2019)
Three-Dimensional Tumor Models to Study Cancer Stemness-Mediated Drug Resistance
Stemness signature and targeted therapeutic drugs identification for Triple Negative Breast Cancer
HOXD3 Plays a Critical Role in Breast Cancer Stemness and Drug Resistance
Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance in drug-adapted cancer cells
Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance in drug-adapted cancer cells
Differential drug resistance acquisition to doxorubicin and paclitaxel in breast cancer cells
Treatment of experimental pancreatic cancer by doxorubicin-, mitoxantrone-, and irinitocan-drug eluting beads
PMN-MDSCs modulated by CCL20 from cancer cells promoted breast cancer cell stemness through CXCL2-CXCR2 pathway
Cardiac safety analysis of first-line chemotherapy drug pegylated liposomal doxorubicin in ovarian cancer
AR antagonists develop drug resistance through TOMM20 autophagic degradation-promoted transformation to neuroendocrine prostate cancer
Mapping knowledge translation and innovation processes in Cancer Drug Development: the case of liposomal doxorubicin
Cancer Chemotherapy: Redox‐Responsive Dual Drug Delivery Nanosystem Suppresses Cancer Repopulation by Abrogating Doxorubicin‐Promoted Cancer Stemness, Metastasis, and Drug Resistance (Adv. Sci. 7/2019)
Three-Dimensional Tumor Models to Study Cancer Stemness-Mediated Drug Resistance
Stemness signature and targeted therapeutic drugs identification for Triple Negative Breast Cancer
HOXD3 Plays a Critical Role in Breast Cancer Stemness and Drug Resistance
Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance in drug-adapted cancer cells
Doxorubicin-loaded human serum albumin nanoparticles overcome transporter-mediated drug resistance in drug-adapted cancer cells
Differential drug resistance acquisition to doxorubicin and paclitaxel in breast cancer cells
Treatment of experimental pancreatic cancer by doxorubicin-, mitoxantrone-, and irinitocan-drug eluting beads
PMN-MDSCs modulated by CCL20 from cancer cells promoted breast cancer cell stemness through CXCL2-CXCR2 pathway
Cardiac safety analysis of first-line chemotherapy drug pegylated liposomal doxorubicin in ovarian cancer
AR antagonists develop drug resistance through TOMM20 autophagic degradation-promoted transformation to neuroendocrine prostate cancer